Serum urate levels are not associated with survival in multiple system atrophy

Parkinsonism and Related Disorders

Volumn 17, Issue 5, 2011, Pages 400-401

  Kim, Han Joon ^a   Jeon, Beom S ^a   Lee, Jee Young ^b  

^a Seoul National University College of Medicine   (South Korea)

^b Seoul National University   (South Korea)

Author keywords

Multiple system atrophy (MSA); Survival; Urate

Indexed keywords

URIC ACID;

ADULT; CHILD; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; FEMALE; HUMAN; LETTER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEX DIFFERENCE; SHY DRAGER SYNDROME; SURVIVAL TIME; URIC ACID BLOOD LEVEL;

AGED; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MULTIPLE SYSTEM ATROPHY; RETROSPECTIVE STUDIES; URIC ACID;

EID: 79957945222     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2011.02.002     Document Type: Letter

References (5)

1. Ascherio A., LeWitt P.A., Xu K., Eberly S., Watts A., Matson W.R., et al. Urate as a predictor of the rate of clinical decline in Parkinson disease. Arch Neurol 2009, 66:1460-1468.
2. Kim HJ, Jeon BS, Lee JY, Yun JY. Survival of Korean patients with multiple system atrophy. Mov Disord, published online 1 FEB 2011, doi:10.1002/mds.23580.
3. Quinn N. Multiple system atrophy - the nature of the beast. J Neurol Neurosurg Psychiatry 1989, 52(Suppl.):78-89.
4. Lee J.E., Song S.K., Sohn Y.H., Lee P.H. Uric acid acts as a potential disease modifier in patients with multiple system atrophy. J Korean Neurol Assoc 2010, 28(Suppl. 2):7.
5. Watanabe H., Saito Y., Terao S., Ando T., Kachi T., Mukai E., et al. Progression and prognosis in multiple system atrophy: an analysis of 230 Japanese patients. Brain 2002, 125:1070-1083.